Results 121 to 130 of about 31,245 (265)

Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies. [PDF]

J Mark Access Health Policy
Blandy O, Lembo P, Folorunso R, Myren KJ, Chevrou-Severac H, Thomas SK.   +5 more
europepmc   +1 more source

Learning Networks Drive Environmental Innovation: Evidence From Fourth‐Stage Purification Diffusion

Environmental Policy and Governance, EarlyView.
ABSTRACT Contaminants of emerging concern, including pharmaceuticals and industrial chemicals, threaten water quality globally. In the European Union (EU), until the adoption of the revised Urban Wastewater Treatment Directive in 2024, a regulatory gap had left the member states and the municipalities in them without binding removal standards ...
Simon Bulian, Jale Tosun, Katrina Smith Korfmacher, Theresa Baur   +3 more
wiley   +1 more source

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention. [PDF]

J Headache Pain
Guerzoni S, Pellesi L, Giannessi L, Lo Castro F, Olivieri MC, Degli Esposti L, Gandolfi F.   +6 more
europepmc   +1 more source

Regional Differences, Distributional Dynamics and Spatial Convergence of Pharmacist Human Resources in China: A Healthcare Tiers Difference Perspective

Risk Management and Healthcare Policy
Bo Ding,1 Run Zhao,2 Xinyi Yue,2 Dexun Li2 1Pharmacy Department, Hefei Maternal and Child Health Hospital, Hefei, People’s Republic of China; 2School of Pharmaceutical Economics and Management, Anhui University of Chinese Medicine, Hefei, People’s ...
Ding B, Zhao R, Yue X, Li D
doaj  

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Consumer preferences for the development of new emulsion products based on vegetable and animal fats. [PDF]

PLoS One
Kowalska M, Woźniak M, Golec K, Zbikowska A, Szakiel J, Turek P.   +5 more
europepmc   +1 more source

Application, Challenges, and Prospects of Non‐Thermal Processing Technologies for Seaweed Protein Extraction—A Review

Food Chemistry International, EarlyView.
This review highlights non‐thermal extraction technologies for seaweed proteins, emphasizing their mechanisms, impacts on protein structure and functionality, and sustainability potential. Key limitations related to species dependence, extract complexity, and scale‐up are discussed to guide future industrial and biorefinery applications.
Rahat Mahmud, Md Fuad Al Hasan, Shuvojit Roy, Tanvir Ahmed   +3 more
wiley   +1 more source

Association of 340B entity eligibility with changes in hospital financial performance. [PDF]

Health Aff Sch
Masia N, Campbell JD, Feyman Y, Finegold K.   +3 more
europepmc   +1 more source

Pharmaceutical Pricing and R&D as a Global Public Good

Health Economics, EarlyView.
ABSTRACT This paper examines the international variation in the prices of branded pharmaceuticals. We consider short‐run profits, or quasi‐rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals.
H. E. Frech III, Mark V. Pauly, William S. Comanor, Joseph R. Martinez   +3 more
wiley   +1 more source

Health-economic challenges for new Alzheimer's disease treatments. [PDF]

J Prev Alzheimers Dis
Fu J, Sköldunger A, Bradshaw A, Broulíková HM, Brück CC, Chapel JM, Grimm S, Hansson A, Herring WL, Hlávka J, Hoang MT, Jönsson L, Landeiro F, Mar J, McKean A, Misik M, Neumann P, Rapp T, Ritchie C, Schiel A, Sun Y, Trépel D, Trueman D, van der Veere PJ, van Rosmalen L, Vonsy JL, Walker L, Wimo A, Winblad B, Xia X, Handels R.   +30 more
europepmc   +1 more source